disease 3,198 words KG: ent-dise-36887af5
Contents

Neuromyelitis Optica Spectrum Disorder (NMOSD)

Disease Info
Prevalence1-10 per 100,000 population 4
Geographic variationHigher prevalence in Asian, African, and Latin American populations
Age of onsetMean 30-40 years (range: <10 to >70)
Gender distributionStrong female predominance (F:M = 9:1)
EthnicityMore common in non-European populations
IncidenceApproximately 0.5-4 per 100,000 person-years
HLA associationsHLA-DRB1*03:01 and HLA-DPB1*05:01 associated with increased risk
AQP4 polymorphismsCertain haplotypes increase susceptibility
Familial casesRare but reported, suggesting shared genetic susceptibility
LocationPerivascular and pial astrocyte processes
FunctionWater homeostasis, glutamate clearance, potassium buffering
ExpressionHighest in optic nerve, spinal cord, hypothalamus, circumventricular organs
DatabasesOMIMOrphanetClinicalTrialsPubMed

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

OMIMMeSHWikipedia

Related Hypotheses (5)

SASP-Driven Aquaporin-4 Dysregulation
Score: 0.78
Aquaporin-4 Polarization Rescue
Score: 0.73
Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.68

Related Analyses (8)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Metabolic reprogramming in neurodegenerative disease
neurodegeneration · completed

Related Experiments (7)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · completed · Score: 0.90
CSF Dynamic Biomarkers for Differential Diagnosis of NPH vs
clinical · proposed · Score: 0.90
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.